Related Experiment Video
Updated: Aug 6, 2026
02:46
A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
Published on: January 20, 2023
Life-threatening bleomycin pulmonary toxicity with ultimate reversibility
L C Hartmann1, S Frytak, R L Richardson
1Department of Medical Oncology, Mayo Clinic, Rochester, MN.
Chest
|August 1, 1990
Summary
Severe pulmonary toxicity from bleomycin chemotherapy can be treated effectively. Aggressive management with steroids and oxygen improved a patient's lung function, suggesting this approach is warranted for bleomycin-induced pneumonitis.
Area of Science:
- Oncology
- Pulmonology
- Toxicology
Background:
- Advanced seminoma treatment often involves chemotherapy regimens including cisplatin, etoposide, and bleomycin.
- Bleomycin is known to cause pulmonary toxicity, a potentially severe side effect.
Observation:
- A 60-year-old man receiving bleomycin-based chemotherapy developed severe pneumonitis.
- Chest X-ray revealed diffuse infiltrates, and arterial blood gas analysis showed a low partial pressure of oxygen (PaO2) of 32 mm Hg.
Findings:
- The patient was treated with corticosteroids and high fraction of inspired oxygen (FiO2) for several days.
- This aggressive management led to survival and marked improvement in pulmonary status.
Implications:
- Severe bleomycin-induced pneumonitis can be managed aggressively and successfully.
- Early and intensive intervention may be crucial for improving outcomes in patients with chemotherapy-induced lung injury.
More Related Videos
Related Concept Videos
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.